The diversity of experimental systems used to study the effects of Notch signaling, pleiotropy of Notch signals, and increased appreciation of Notch involvement in disease has made the “Notch field” explode in the past decade.  In 2007 we launched a biennial general Notch research meeting that aims to reflect the diversity of Notch research and bring together researchers from different fields and different experimental systems interested in Notch signaling. This first meeting was a thunderous success and confirmed our belief that such a regular meeting will allow each of us to become better informed about what is happening in spheres of interest not immediately connected with our own, get a feeling about the trends and most exciting developments in the field, explore medical Notch applications, and hear and meet old and new players.  Interspersed with these general meetings, in alternating years, more focused smaller workshops will help to explore specific thematic in more depth. The first such workshop with the title “Notch and Cancer” was held in 2008.

These meetings are sponsored by the not for profit foundation Fondation Sante (www.FondationSante.org) and benefit from the generosity of additional sponsors. The provisional program includes sessions and confirmed speakers. There will also be a poster session. The program will not be firmly set before early summer.

We will not be able to accept more than 330 participants but encourage the participation of junior researchers as well as colleagues new to the field.

Organizing Committee

Iannis Aifantis, New York University (NYU) School of Medicine, USA; Spyros Artavanis-Tsakonas, Harvard Medical School, USA; Doug Barrick, The Johns Hopkins University, USA; Anna Bigas, IDIBELL, Spain; Stephen Blacklow, Brigham and Women's Hospital, Harvard Medical School, USA; Sarah Bray, University of Cambridge, UK; Tony Capobianco, University of Miami School of Medicine, USA; Christos Delidakis, Institute of Molecular Biology and Biotechnology, FoRTH, Greece; Mark Fortini, Thomas Jefferson University, USA; Anne Hart, MGH and Harvard Medical School, USA; Tasuku Honjo, Kyoto University Graduate School of Medicine, Japan; Alain Israel, Institut Pasteur, France; Ryoichiro Kageyama, Institute for Virus Research, Kyoto University, Japan; Thomas Klein, Institute for Genetics, University of Cologne, Germany; Raphael Kopan, Washington University School of Medicine, USA; Urban Lendahl, Karolinska Institute, Sweden; Angeliki Louvi, Yale University School of Medicine, USA; Kenji Matsuno, Tokyo University of Science, Japan; Lucio Miele, Loyola University Chicago, USA; Marco Milán, IRB Barcelona, Spain; Benjamin Ohlstein, Columbia University Medical Center, USA; Barbara Osborne, University of Massachusetts Amherst USA; Isabella Screpanti, University "La Sapienza", Italy; Gerry Weinmaster, David Geffen School of Medicine, UCLA, USA.